SB Management’s GeneDx Holdings WGS Stock Holding History

SB Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-225,771	Closed	-$22.9M	–	6
2022 Q1	$22.9M	Sell	225,771 -47,609	-17%	-$5.29M	4.43%	6
2021 Q4	$40.2M	Hold	273,380	–	–	3.98%	6
2021 Q3	$68.5M	Buy	273,380 +145,207	+113%	+$49.9M	7.02%	3
2021 Q2	$59.3M	Buy	128,173 +25,758	+25%	+$11.1M	0.7%	6
2021 Q1	$50.3M	Buy	+102,415	New	+$53.3M	0.32%	13

Other funds holding WGS

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SB Management's WGS Position: Q2 2022 in Review

SB Management sold out of GeneDx Holdings (WGS) in Q2 2022, closing a stake of 225,771 shares — an estimated $22.9M sold.

SB Management first reported a position in WGS in Q1 2021 and held it in 5 quarters. The position peaked at $68.5M in Q3 2021. 111 funds tracked by Wall St. Rank hold WGS as of Q2 2022.

SB Management reported no remaining GeneDx Holdings position as of Q2 2022 after selling out during the quarter.
SB Management sold 225,771 GeneDx Holdings shares in Q2 2022, an estimated $22.9M.
SB Management first reported a position in GeneDx Holdings in Q1 2021 and held it in 5 quarters.
SB Management's GeneDx Holdings position peaked at $68.5M in Q3 2021.
111 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2022.

Based on SB Management's 13F filing for Q2 2022.